Oric Pharmaceuticals (ORIC) Prepaid Assets (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Prepaid Assets came in at $8.3 million in Q1 2026, up 7.67% YoY from $7.7 million in Q1 2025, and up 18.96% on a QoQ basis from $7.0 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Prepaid Assets (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Prepaid Assets data on file, last reported at $8.3 million in Q1 2026.
- Quarterly Prepaid Assets rose 7.67% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (up 7.67% YoY) and the FY2025 annual result came in at $7.0 million, up 10.94% from the prior year.
- Prepaid Assets grew to $8.3 million in Q1 2026, from $7.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $8.6 million in Q2 2025 to a low of $3.5 million in Q1 2023.
- A 5-year average of $6.2 million and a median of $6.5 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 127.7% — and 2023, when it tumbled 35.02%.
- Tracing ORIC's Prepaid Assets over 5 years: stood at $4.2 million in 2022, then gained by 5.38% to $4.4 million in 2023, then surged by 42.63% to $6.3 million in 2024, then rose by 10.94% to $7.0 million in 2025, then gained by 18.96% to $8.3 million in 2026.
- The last three Prepaid Assets figures came in at $8.3 million (Q1 2026), $7.0 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.93 Mn |
| Mar 31, 2026 | 8.30 Mn |
| Dec 31, 2025 | 6.98 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 8.61 Mn |
| Mar 31, 2025 | 7.71 Mn |
| Dec 31, 2024 | 6.29 Mn |
| Sep 30, 2024 | 7.06 Mn |
| Jun 30, 2024 | 8.19 Mn |
| Mar 31, 2024 | 7.31 Mn |
| Dec 31, 2023 | 4.41 Mn |
| Sep 30, 2023 | 4.94 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Mar 31, 2023 | 3.54 Mn |
| Dec 31, 2022 | 4.19 Mn |
| Sep 30, 2022 | 5.03 Mn |
| Jun 30, 2022 | 6.46 Mn |
| Mar 31, 2022 | 4.46 Mn |
| Dec 31, 2021 | 3.54 Mn |
| Sep 30, 2021 | 3.33 Mn |